Verano Opens MÜV North Miami-Biscayne, the Company’s Second Miami Dispensary and 73rd Florida Location
· MÜV North Miami-Biscayne, situated at 12395 Biscayne Boulevard, adds a second MÜV location in Florida’s largest metro area, Miami-Dade County, with more than 2.7 million residents^1
· Verano’s active operations span 13 states, comprised of 136 dispensaries and 14 cultivation and processing facilities with more than 1 million square feet of cultivation capacity
CHICAGO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (NEO: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of MÜV North Miami-Biscayne on Friday, November 17^th, the Company’s 73^rd Florida dispensary and 136^th location nationwide. MÜV North Miami-Biscayne, located at 12395 Biscayne Blvd, will be open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m., local time.
MÜV North Miami-Biscayne – Verano’s second dispensary in Florida’s largest metropolitan area with more than 2.7 million residents^1 – adds another complementary location to the Company’s existing MÜV Miami-Kendall dispensary situated on the city’s Southwest side.
“We are so excited to open MÜV North Miami on beautiful Biscayne Boulevard,” said Joel Noonan, EVP of the Southern Region. “Adding a second MÜV location in Florida’s largest market provides another convenient location for the Miami medical cannabis community to access our patient-centric service and wide variety of high quality products in a warm and welcoming environment. We’re thrilled to join the North Miami community and look forward to welcoming patients at MÜV North Miami-Biscayne for years to come.”
MÜV dispensaries feature online menus for effortless browsing of their extensive, award-winning product selection, including the Company’s signature Verano Reserve, MÜV and Sweet Supply flower, Encore edibles, On the Rocks concentrates and extracts, and Savvy flower and extracts, spanning an array of categories. The Company also offers one-on-one virtual and in-store consultations at no cost to patients and provides patient-centric concierge services via phone, email, web chat and text to address patient questions and inquiries.
For additional convenience and accessibility, patients can visit muvfl.com or the MÜV mobile application - available in the Google Play and Apple App stores - for additional information and to place orders for express in-store pickup.
Product images, logos and b-roll footage are available on the Company Newsroom.
*About Verano*
Verano Holdings Corp. (NEO: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano offers a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf^™ and MÜV^™ dispensary banners and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano^™, MÜV^™, Savvy^™, BITS^™, Encore^™, and Avexia^™. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1,000,000 square feet of cultivation capacity. Learn more at www.verano.com.
*Contacts:*
*Media *
Verano
Grace Bondy
Senior Manager, Communications
Grace.Bondy@verano.com
*Investors *
Verano
Julianna Paterra, CFA
Vice President, Investor Relations
Julianna.Paterra@verano.com
*Forward Looking Statements*
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
###
--------------------
^1 Source: U.S. Census